Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19

Afef Yakoubi1, Cyrine El Baher Dhafer2

  • 1Laboratory of Hetero-organic Compounds and Nanostructured Materials, Chemistry Department, Faculty of Sciences Bizerte, University of Carthage, LR 18 ES11, 7021 Bizerte, Tunisia.

Insights

Nanotechnology, particularly plasmonic nanoparticles, offers innovative solutions for detecting, treating, and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This approach is crucial for developing rapid diagnostics and effective therapeutics against COVID-19 and future viral threats.

Area of Science:

  • Nanomedicine
  • Materials Science
  • Virology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents significant global health, economic, and environmental challenges.
  • Viral mutations necessitate continuous development of vaccines, diagnostics, and therapeutics.
  • Nanotechnology offers promising avenues for novel strategies against COVID-19.

Purpose of the Study:

  • To review platforms using plasmonic nanoparticles for SARS-CoV-2 detection, treatment, and prevention.
  • To highlight the properties of plasmonic nanoparticles in point-of-care diagnostics.
  • To discuss challenges and future perspectives for clinical translation of nanotechnology-based COVID-19 solutions.

Main Methods:

  • Review of existing literature on plasmonic nanoparticle applications for COVID-19.
  • Selection of optimal strategies for detection, treatment, and prevention.
  • Analysis of nanoparticle properties relevant to diagnostic and therapeutic development.

Main Results:

  • Plasmonic nanoparticles show potential for sensitive and rapid detection of SARS-CoV-2.
  • Nanoparticle-based strategies can be applied to antiviral therapies and preventative measures.
  • Metallic plasmon nanoparticles are particularly relevant for point-of-care diagnostic tools.

Conclusions:

  • Nanotechnology, especially plasmonic nanoparticles, provides versatile tools for combating COVID-19.
  • Further research is needed to address challenges in clinical translation and commercialization.
  • These advancements are vital for preparedness against future pandemics.

Related Concept Videos